PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Clinicopathological features of second primary lung cancer and pulmonary metastasisin patients with breast cancer.

Abstract For isolated pulmonary nodules in patients with breast cancer, especially for those with elder age, larger tumor size and radiotherapy history, we should distinguish the second primary lung cancer from pulmonary metastasis. The treatment regimen for lung metastasis and primary lung cancer in patients with breast cancer are entirely distinct. The timely histopathology examinations for pulmonary nodes in patients with breast cancer are recommended.
PMID
Related Publications

Risk Stratification For Axillary Lymph Node Metastases in Breast Cancer Patients: What Clinicopathological and Radiological Factors of Primary Breast Cancer Can Predict Preoperatively Axillary Lymph Node Metastases?

Solitary pulmonary nodules in patients with extrapulmonary neoplasms.

The availability of pre- and intraoperative evaluation of a solitary pulmonary nodule in breast cancer patients.

Clinicopathological characteristics and prognosis of different molecular types of breast cancer.

Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases.

Authors

Mayor MeshTerms
Keywords

Breast neoplasms

Diagnosis

Lung neoplasms

Neoplasms metastasis, lung

Risk factors

Journal Title zhonghua zhong liu za zhi [chinese journal of oncology]
Publication Year Start




PMID- 29575839
OWN - NLM
STAT- MEDLINE
DCOM- 20180406
LR  - 20180406
IS  - 0253-3766 (Print)
IS  - 0253-3766 (Linking)
VI  - 40
IP  - 3
DP  - 2018 Mar 23
TI  - [Clinicopathological features of second primary lung cancer and pulmonary
      metastasisin patients with breast cancer].
PG  - 201-205
LID - 10.3760/cma.j.issn.0253-3766.2018.03.008 [doi]
AB  - Objective: To compare the clinicopathological characteristics of second primary
      lung cancer following breast cancer and lung metastases from breast cancer, and
      then to analyze the risk factors in breast cancer patients with second primary
      lung tumor. Methods: Clinical data of 55 breast cancer patients with second
      primary lung tumor and 205 breast cancer patients with solitary pulmonary
      metastasis in Shandong Cancer Hospital from January 2006 to January 2017 were
      retrospectively analyzed. The risk factors of primary lung cancer following
      breast cancer were analyzed using logistic regression model. Results: Second
      primary lung cancer in patients with first breast cancer accounted for
      approximately 21.2%(55/260) of pulmonary malignant solitary nodules, and
      0.84%(55/6 580) of all breast cancer patients. The median intervals between the
      diagnosis of second primary lung cancer or lung metastasis and first breast
      cancer were 52 months and 42 months, respectively. These two groups showed
      significant difference between age, time interval between diagnoses, breast tumor
      size, axillary lymph node metastasis, estrogen receptor, molecular subtype
      (luminal B and triple-negative) and history of radiotherapy (P<0.05 for all). A
      multivariate logistic regression model confirmed that age (OR=1.088, P<0.001),
      breast tumor size(OR=0.480, P<0.001), and radiotherapy history (OR=3.460,
      P=0.004) were all independent factors for second primary lung cancer.
      Conclusions: For isolated pulmonary nodules in patients with breast cancer,
      especially for those with elder age, larger tumor size and radiotherapy history, 
      we should distinguish the second primary lung cancer from pulmonary metastasis.
      The treatment regimen for lung metastasis and primary lung cancer in patients
      with breast cancer are entirely distinct. The timely histopathology examinations 
      for pulmonary nodes in patients with breast cancer are recommended.
FAU - He, K W
AU  - He KW
AD  - School of Medicine and Life Sciences, University of Jinan, Shandong Academy of
      Medical Science, Jinan 250062, China.
FAU - Wei, W
AU  - Wei W
AD  - Department of Surgery, Xintai People's Hospital, Taian 271200, China.
FAU - Liu, Z Y
AU  - Liu ZY
AD  - School of Medicine and Life Sciences, University of Jinan, Shandong Academy of
      Medical Science, Jinan 250062, China.
FAU - Song, X
AU  - Song X
AD  - School of Medicine and Life Sciences, University of Jinan, Shandong Academy of
      Medical Science, Jinan 250062, China.
FAU - Zhuo, P Y
AU  - Zhuo PY
AD  - Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong
      University, Shandong Academy of Medical Science, Jinan 250117, China.
FAU - Ma, Q H
AU  - Ma QH
AD  - Department of Breast Surgery, Shandong Cancer Hospital Affiliated to Shandong
      University, Shandong Academy of Medical Science, Jinan 250117, China.
FAU - Yu, Z Y
AU  - Yu ZY
AD  - Department of Breast Surgery, Shandong Cancer Hospital Affiliated to Shandong
      University, Shandong Academy of Medical Science, Jinan 250117, China.
LA  - chi
PT  - Journal Article
PL  - China
TA  - Zhonghua Zhong Liu Za Zhi
JT  - Zhonghua zhong liu za zhi [Chinese journal of oncology]
JID - 7910681
RN  - 0 (Receptors, Estrogen)
SB  - IM
MH  - Age Factors
MH  - Axilla
MH  - Breast Neoplasms/chemistry/*pathology
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Lung Neoplasms/*pathology/*secondary
MH  - Lymph Nodes/pathology
MH  - Lymphatic Metastasis
MH  - Neoplasms, Second Primary/*pathology
MH  - Receptors, Estrogen
MH  - Retrospective Studies
MH  - Solitary Pulmonary Nodule/*pathology
MH  - Time Factors
OTO - NOTNLM
OT  - Breast neoplasms
OT  - Diagnosis
OT  - Lung neoplasms
OT  - Neoplasms metastasis, lung
OT  - Risk factors
EDAT- 2018/03/27 06:00
MHDA- 2018/04/07 06:00
CRDT- 2018/03/27 06:00
PHST- 2018/03/27 06:00 [entrez]
PHST- 2018/03/27 06:00 [pubmed]
PHST- 2018/04/07 06:00 [medline]
PST - ppublish
SO  - Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):201-205.